Idera Pharmaceuticals Announces Final Clinical Safety and Efficacy Data from ILLUMINATE-204 Trial in Advanced Melanoma

Ads

You May Also Like

Paratek to Present Clinical Findings at ECCMID 2016

BOSTON, March 29, 2016 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) announced today that ...

Celldex Therapeutics Announces Appointment to Board of Directors

HAMPTON, N.J., Dec. 14, 2016 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced ...